M. Kneussl (Vienna, Austria), A. Peacock (Glasgow, United Kingdom)
Atrial fibrillation is not a predictor of in-hospital mortality in pulmonary embolism
G. Koracevic, V. Atanaskovic, S. Salinger, M. Zivkovic, S. Radicevic, V. Topic, D. Kutlesic (Nis, Serbia And Montenegro)
|  |
Long term treatment of pulmonary embolism (PE) with low molecular weight heparin (LMWH) (tinzaparin). Preliminary results
A. Varela, D. Lekkos, C. Michalopoulou, M. Stroumpou, N. Mparampatis, D. Georgopoulos, I. Lichros (Patras, Greece)
| |
Retrospective evaluation of cases with pulmonary thromboembolism
G. Polat, M. Buyuksirin, Z. Asuk, G. Karadeniz, G. Tibet (Izmir, Turkey)
|  |
The role of electrocardiography in the course of pulmonary thromboembolism
N. Kokturk, H. Kilic, A. Varol, S. Akinci, N. Ekim (Ankara, Turkey)
| |
Long term follow up in patients with vena cava filter
G. Okumus, R. Unver, K. Guven, E. Terzibasoglu, E. Kiyan, H. Issever, O. Arseven (Istanbul, Turkey)
| |
Pulmonary thromboembolic disease – an observational study in internal medicine department
D. Tofolean, T. Adam, L. Mazilu, F. Voinea (Constantza, Romania)
| |
Heparin-induced thrombocytopenia in patients with massive lung embolism, left-sided pneumonia and uterine tumor
M. Rozek, A. Doboszynska, E. Sosnowska, I. Tomaszewska (Warsaw, Poland)
| |
Septic pulmonary embolism; report of three cases
Z. Celebi Sozener, A. Kaya, C. Atasoy, M. Kilickap, I. Savas, N. Numanoglu (Ankara, Turkey)
| |
A case of antiphospholipid antibody syndrome became pregnant under warfarin treatment
N. Kalac, B. Gebesoglu, L. Yilmaz Aydin, T. Sipahi, F. Kara, A. Zenciroglu (Ankara, Turkey)
| |
Frequency of pulmonary embolism in patients after cerebro-vascular insult
A. Arsovska, A. Popovski, Z. Arsovski (Skopje, Fyrom)
| |
Prevalence and incidence of deep venous thrombosis among patients in intensive care unit
X. Xu, S. Liu (Beijing, China)
| |
Single slice CTPA and VUS for evaluation of pulmonary embolism
T. Gatheral, N. Adams (Worthing, West Sussex, United Kingdom)
| |
Thromboprophylaxis in medical in-patients: are we there yet?
M. Paracha, M. Javed, G. Bhat (Blackpool, Bolton, United Kingdom)
| |
Variance between clinical opinion and practice in the prescription of thromboprophylaxis for medical patients
R. Heinink, S. Saraf, K. Barnett, R. Harris, C. McNeill, R. Lodwick (Wolverhampton, United Kingdom)
| |
Quantitative D-dimer levels in pulmonary thromboembolism and community acquired pneumonia
N. Kokturk, A. Varol, H. Kilic, N. Ekim (Ankara, Turkey)
| |
PaO2/FiO2 ratio in pulmonary embolism; does it help in assessing pretest probability?
S. Khalid, S. Bailey, C. Houghton, G. Kwong (Bury, United Kingdom)
| |
Pulmonary embolism (PE): potencial risk factors and discrepancies between clinical and postmortem diagnosis in a referral hospital of lung diseases
R. Baez-Saldana, J. Rodriguez-Barragan, E. Pena-Mirabal (Mexico City, Mexico)
| |
Efficiency of r-TPA therapy in major venous thromboembolism
S. Kaya, H. C. Hasanoglu, A. Karalezli, E. Yeter (Ankara, Turkey)
| |
Assessment of Wells criteria in treated pulmonary emboli patients
P. Adimi Naghan, R. Seiedi, M. Malek Mohammad, A. Kianee, S. Zahirifard, M. R. Masjedi (Tehran, Islamic Republic Of Iran)
| |